Application of quality by design to formulation and processing of protein liposomes.

Quality by design (QbD) principles were explored in the current study to gain a comprehensive understanding of the preparation of superoxide dismutase (SOD) containing liposome formulations prepared using freeze-and-thaw unilamellar vesicles (FAT-ULV). Risk analysis and D-optimal statistical design were performed. Of all the variables investigated, lipid concentration, cholesterol mol%, main lipid type and protein concentration were identified as critical parameters affecting SOD encapsulation efficiency, while the main lipid type was the only factor influencing liposome particle size. Using a model generated by the D-optimal design, a series of three-dimensional response spaces for SOD liposome encapsulation efficiency were established. The maximum values observed in the response surfaces indirectly confirmed the existence of a specific SOD-lipid interaction, which took place in the lipid bilayer under the following optimal conditions: (1) appropriate membrane thickness and curvature (DPPC liposomes); and (2) optimal "pocket size" generated by cholesterol content. With respect to storage stability, the prepared SOD liposomes remained stable for at least 6 months in aqueous dispersion state at 4°C. This research highlights the level of understanding that can be accomplished through a well-designed study based on the philosophy of QbD.

[1]  Y. Barenholz,et al.  Gelation of liposome interior A novel method for drug encapsulation , 1992, FEBS letters.

[2]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[3]  I. Fridovich,et al.  Further characterization of bovine superoxide dismutase and its isolation from bovine heart. , 1971, The Journal of biological chemistry.

[4]  P. Cullis,et al.  Developments in liposomal drug delivery systems , 2001, Expert opinion on biological therapy.

[5]  Yifan Ma,et al.  PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Yong-jie Wu,et al.  Anti-inflammatory effect of recombinant human superoxide dismutase in rats and mice and its mechanism. , 2002, Acta pharmacologica Sinica.

[7]  S. Leucuţa,et al.  Optimization of hydrophilic matrix tablets using a D-optimal design , 1997 .

[8]  D. Burgess,et al.  Liposomes as Carriers for Controlled Drug Delivery , 2012 .

[9]  Diane J Burgess,et al.  A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. , 2011, International journal of pharmaceutics.

[10]  Mansoor A. Khan,et al.  PROCESS CONTROL PERSPECTIVE FOR PROCESS ANALYTICAL TECHNOLOGY: INTEGRATION OF CHEMICAL ENGINEERING PRACTICE INTO SEMICONDUCTOR AND PHARMACEUTICAL INDUSTRIES , 2007 .

[11]  Lawrence X. Yu Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.

[12]  J. Marsh,et al.  Mechanical properties of vesicles. II. A model for osmotic swelling and lysis. , 1993, Biophysical journal.

[13]  S. Lim,et al.  The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol , 2005, Journal of liposome research.

[14]  Anthony C. Atkinson,et al.  Optimum Experimental Designs, with SAS , 2007 .

[15]  Olaf S Andersen,et al.  Bilayer thickness and membrane protein function: an energetic perspective. , 2007, Annual review of biophysics and biomolecular structure.

[16]  M. Khan,et al.  Predicting hydrophilic drug encapsulation inside unilamellar liposomes. , 2012, International journal of pharmaceutics.

[17]  Vladimir P Torchilin,et al.  Peptide and protein drug delivery to and into tumors: challenges and solutions. , 2003, Drug discovery today.

[18]  Nils B. Vogt Quality by design managing research and development , 1992 .

[19]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[20]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[21]  E. Evans,et al.  Effect of chain length and unsaturation on elasticity of lipid bilayers. , 2000, Biophysical journal.

[22]  Antonio P. Costa,et al.  Protein Encapsulation in Unilamellar Liposomes: High Encapsulation Efficiency and A Novel Technique to Assess Lipid-Protein Interaction , 2012, Pharmaceutical Research.

[23]  I. Fridovich,et al.  Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver , 2001, The Journal of Biological Chemistry.

[24]  Diane J Burgess,et al.  A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. , 2012, International journal of pharmaceutics.

[25]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[26]  James K Drennen,et al.  A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation. , 2006, Journal of pharmaceutical sciences.